Injectable Labetalol Hydrochloride Recalled Due to Incomplete Crimp Seals
Pfizer recalls 220,400 cartridges of Labetalol Hydrochloride injection due to potential incomplete crimp seals that could compromise sterility. Affected lots should not be used; healthcare providers should contact Pfizer for guidance.
- Product
- LABETALOL HYDROCHLORIDE — LABETALOL HYDROCHLORIDE (LABETALOL HYDROCHLORIDE)
- Category
- Drug
- Distribution
- Distributed nationwide